Kim YK, Jang CW, Kwon SH, et al. - Researchers examined the long-term clinical results of an intermediate lesion (IL) according to the presence of a combined culprit lesion (CCL), hypothesizing that presence of a CCL may impact long-term clinical results of IL. They studied angiographic findings (n = 1096) and medical chart. Participants with IL were split into two categories: IL without CCL group (n = 383, 64.5%) and IL with CCL group (n = 211, 35.5%). Significantly higher major adverse cardiovascular events occurred in the IL with CCL group vs those in the IL without CCL group, as revealed during a mean follow up span of 118.4 ± 5.5 months. Findings thus demonstrated better 10-year clinical results of an IL (especially IL without CCL), when compared with those of stented lesions. These data indicate that it is safe to follow-up IL in sites that do not have ability to evaluate functional study.